Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 22,362.0 | 1,569.0 | 1,360.0 | 1,404.0 | 1,418.0 | 1,253.0 | 16,291.0 | 15,997.0 |
| Revenue growth | 1325.2% | 15.4% | -3.1% | -1.0% | 13.2% | -92.3% | 1.8% | -14.1% |
| Cost of goods sold | 0.0 | 14,643.0 | 13,747.0 | 13,534.0 | 12,853.0 | 11,876.0 | 12,319.0 | 11,060.0 |
| Gross profit | 22,362.0 | -13,074.0 | -12,387.0 | -12,130.0 | -11,435.0 | -10,623.0 | 3,972.0 | 4,937.0 |
| Gross margin | 100.0% | -833.3% | -910.8% | -864.0% | -806.4% | -847.8% | 24.4% | 30.9% |
| Selling, general and administrative | 71.0 | 4,779.0 | 4,480.0 | 4,580.0 | 4,281.0 | 4,563.0 | 3,525.0 | 3,459.0 |
| EBITA | 22,362.0 | 3,202.0 | 2,532.0 | 2,795.0 | 2,113.0 | 1,053.0 | 778.0 | 1,807.0 |
| EBITA margin | 100.0% | 204.1% | 186.2% | 199.1% | 149.0% | 84.0% | 4.8% | 11.3% |
| Amortization of intangibles | 71.0 | 71.0 | 72.0 | 66.0 | 68.0 | 14.0 | 4.0 | 4.0 |
| EBIT | 22,291.0 | 3,131.0 | 2,460.0 | 2,729.0 | 2,045.0 | 1,039.0 | 774.0 | 1,803.0 |
| EBIT margin | 99.7% | 199.6% | 180.9% | 194.4% | 144.2% | 82.9% | 4.8% | 11.3% |
| Pre-tax income | 2,258.0 | 2,896.0 | 2,120.0 | 2,560.0 | 1,753.0 | 723.0 | 447.0 | 1,478.0 |
| Income taxes | 443.0 | 531.0 | 383.0 | 475.0 | 268.0 | 985.0 | -166.0 | 289.0 |
| Tax rate | 19.6% | 18.3% | 18.1% | 18.6% | 15.3% | 136.2% | | 19.6% |
| Earnings from continuing ops | 1,794.0 | 2,344.0 | 1,716.0 | 2,064.0 | 1,479.0 | -262.0 | 896.0 | 696.0 |
| Earnings from discontinued ops | | | | | 322.0 | -2,869.0 | | 493.0 |
| Net income | 1,794.0 | 2,344.0 | 1,716.0 | 2,064.0 | 1,801.0 | -3,131.0 | 896.0 | 1,189.0 |
| Net margin | 8.0% | 149.4% | 126.2% | 147.0% | 127.0% | -249.9% | 5.5% | 7.4% |
| |
| Diluted EPS | | $6.62 | $4.76 | $5.66 | $4.06 | ($0.72) | $2.27 | $1.64 |
| Shares outstanding (diluted) | | 354.1 | 360.6 | 364.9 | 364.1 | 363.7 | 394.8 | 425.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|